Faith and fitness: new study tests church program to fight heart disease in black men

NCT ID NCT07220213

Recruiting now Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 24-week church-based program called FELLAship for Black men at risk of heart disease, diabetes, and obesity. Participants attend weekly sessions with exercise and health education, get coaching, and use a smartwatch to track progress. The goal is to see if the program improves blood pressure, cholesterol, and blood sugar.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FELLAship program (behavioral intervention: health education, physical activity, coaching)
What this could lead to: If successful, this could show that a church-based program helps Black men lower their risk for heart disease and diabetes.
What could go wrong: This is a small, early-stage study with only 90 participants, so results may not apply to all Black men. The program requires weekly attendance, which may be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD SUGAR; HIGH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypercholesterolemia hyperglycemia hyperlipidemia Obesity obesity disorder Overweight type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD SUGAR; HIGH DIABETE TYPE 2 DIABETES TYPE 2 HIGH BLOOD GLUCOSE HIGH CHOLESTEROL HIGH CHOLESTEROL/HYPERLIPIDEMIA OBESITY & OVERWEIGHT

Contacts and locations

Locations

The Worship Center Cristian Church
RECRUITING

Birmingham, Alabama, 35210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.